These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29978304)

  • 1. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.
    Bellés A; Bueno J; Rojo-Bezares B; Torres C; Javier Castillo F; Sáenz Y; Seral C
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1847-1856. PubMed ID: 29978304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital.
    Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y
    J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron.
    Chairat S; Ben Yahia H; Rojo-Bezares B; Sáenz Y; Torres C; Ben Slama K
    J Chemother; 2019 May; 31(3):120-126. PubMed ID: 30849001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
    Toval F; Guzmán-Marte A; Madriz V; Somogyi T; Rodríguez C; García F
    J Med Microbiol; 2015 Jan; 64(Pt 1):37-43. PubMed ID: 25355933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integron diversity in bla
    Savinova TA; Bocharova YA; Lazareva AV; Chebotar IV; Mayanskiy NA
    Klin Lab Diagn; 2019; 64(8):497-502. PubMed ID: 31479607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of
    Arfaoui A; Rojo-Bezares B; Fethi M; López M; Toledano P; Sayem N; Ben Khelifa Melki S; Ouzari HI; Klibi N; Sáenz Y
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38963417
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
    BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular Analysis of Antibiotic Resistance in CarbapenemResistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples].
    Altan G; Rakici E; Özgümüş OB
    Mikrobiyol Bul; 2024 Apr; 58(2):148-170. PubMed ID: 38676583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria.
    Meradji S; Barguigua A; Bentakouk MC; Nayme K; Zerouali K; Mazouz D; Chettibi H; Timinouni M
    Burns; 2016 Jun; 42(4):906-18. PubMed ID: 27156788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.
    Papagiannitsis CC; Medvecky M; Chudejova K; Skalova A; Rotova V; Spanelova P; Jakubu V; Zemlickova H; Hrabak J;
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
    Phoon HYP; Hussin H; Hussain BM; Thong KL
    Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan.
    Mano Y; Saga T; Ishii Y; Yoshizumi A; Bonomo RA; Yamaguchi K; Tateda K
    BMC Microbiol; 2015 Feb; 15():41. PubMed ID: 25881168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O; Juan C; Cercenado E; Navarro F; Bouza E; Coll P; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.
    Edelstein MV; Skleenova EN; Shevchenko OV; D'souza JW; Tapalski DV; Azizov IS; Sukhorukova MV; Pavlukov RA; Kozlov RS; Toleman MA; Walsh TR
    Lancet Infect Dis; 2013 Oct; 13(10):867-76. PubMed ID: 23845533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea.
    Yoo JS; Yang JW; Kim HM; Byeon J; Kim HS; Yoo JI; Chung GT; Lee YS
    Int J Antimicrob Agents; 2012 Apr; 39(4):300-4. PubMed ID: 22325122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.